Page last updated: 2024-08-23

raloxifene hydrochloride and Thrombophilia

raloxifene hydrochloride has been researched along with Thrombophilia in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (75.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Bauer, DC; Clarke, BL; Drake, MT; Tsourdi, E; Yu, EW	1
Baz-Hecht, M; Cosman, F; Cruz, JD; Cushman, M; Lindsay, R; Nieves, JW; Vardy, MD; Zion, M	1
Abildgaard, U; Andresen, MS; Eilertsen, AL; Sandset, PM	1
Gapstur, S; Jordan, VC; Morrow, M	1

Reviews

1 review(s) available for raloxifene hydrochloride and Thrombophilia

Article	Year
Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease. Journal of the National Cancer Institute, 2001, Oct-03, Volume: 93, Issue:19 Topics: Adult; Aged; Bone and Bones; Breast; Breast Neoplasms; Cardiovascular System; Cinnamates; Clinical Trials as Topic; Coronary Disease; Endometrial Neoplasms; Estrogen Replacement Therapy; Female; Heart; Hot Flashes; Humans; Middle Aged; Models, Biological; Organ Specificity; Osteoporosis; Postmenopause; Premenopause; Prospective Studies; Protein Structure, Tertiary; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Receptors, Estrogen; Risk; Risk Assessment; Selective Estrogen Receptor Modulators; Stilbenes; Tamoxifen; Thrombophilia; Transcription, Genetic	2001

Article

Year

Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease.

Journal of the National Cancer Institute, 2001, Oct-03, Volume: 93, Issue:19

Topics: Adult; Aged; Bone and Bones; Breast; Breast Neoplasms; Cardiovascular System; Cinnamates; Clinical Trials as Topic; Coronary Disease; Endometrial Neoplasms; Estrogen Replacement Therapy; Female; Heart; Hot Flashes; Humans; Middle Aged; Models, Biological; Organ Specificity; Osteoporosis; Postmenopause; Premenopause; Prospective Studies; Protein Structure, Tertiary; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Receptors, Estrogen; Risk; Risk Assessment; Selective Estrogen Receptor Modulators; Stilbenes; Tamoxifen; Thrombophilia; Transcription, Genetic

2001

Trials

2 trial(s) available for raloxifene hydrochloride and Thrombophilia

Article	Year
Short-term effects of estrogen, tamoxifen and raloxifene on hemostasis: a randomized-controlled study and review of the literature. Thrombosis research, 2005, Volume: 116, Issue:1 Topics: Biomarkers; Blood Coagulation Factor Inhibitors; Blood Coagulation Factors; Estrogens; Female; Fibrinolysis; Hemostasis; Hormone Replacement Therapy; Humans; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Thrombophilia	2005
Hormone therapy and raloxifene reduce the coagulation inhibitor potential. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2007, Volume: 18, Issue:5 Topics: Aged; Blood Coagulation; Estrogen Antagonists; Estrogen Replacement Therapy; Factor V; Female; Fibrin; Heterozygote; Humans; Middle Aged; Mutation; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Risk Factors; Thrombophilia; Venous Thromboembolism	2007

Article

Year

Short-term effects of estrogen, tamoxifen and raloxifene on hemostasis: a randomized-controlled study and review of the literature.

Thrombosis research, 2005, Volume: 116, Issue:1

Topics: Biomarkers; Blood Coagulation Factor Inhibitors; Blood Coagulation Factors; Estrogens; Female; Fibrinolysis; Hemostasis; Hormone Replacement Therapy; Humans; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Thrombophilia

2005

Hormone therapy and raloxifene reduce the coagulation inhibitor potential.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2007, Volume: 18, Issue:5

Topics: Aged; Blood Coagulation; Estrogen Antagonists; Estrogen Replacement Therapy; Factor V; Female; Fibrin; Heterozygote; Humans; Middle Aged; Mutation; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Risk Factors; Thrombophilia; Venous Thromboembolism

2007

Other Studies

1 other study(ies) available for raloxifene hydrochloride and Thrombophilia

Article	Year
Osteoporosis Management in the Era of COVID-19. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2020, Volume: 35, Issue:6 Topics: Absorptiometry, Photon; Biomarkers; Bone Density; Bone Density Conservation Agents; Continuity of Patient Care; Coronavirus Infections; COVID-19; Denosumab; Disease Management; Drug Administration Schedule; Estrogen Replacement Therapy; Fractures, Spontaneous; Home Care Services; Humans; Immunosuppression Therapy; Osteoporosis; Pandemics; Pneumonia, Viral; Raloxifene Hydrochloride; Recurrence; Telemedicine; Thrombophilia; Unnecessary Procedures	2020

Article

Year

Osteoporosis Management in the Era of COVID-19.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2020, Volume: 35, Issue:6

Topics: Absorptiometry, Photon; Biomarkers; Bone Density; Bone Density Conservation Agents; Continuity of Patient Care; Coronavirus Infections; COVID-19; Denosumab; Disease Management; Drug Administration Schedule; Estrogen Replacement Therapy; Fractures, Spontaneous; Home Care Services; Humans; Immunosuppression Therapy; Osteoporosis; Pandemics; Pneumonia, Viral; Raloxifene Hydrochloride; Recurrence; Telemedicine; Thrombophilia; Unnecessary Procedures

2020